Cogstate Presentations at CTAD 2019
Thursday, Dec 5th
11:30am – Oral Communication
OC5 – Development of cognitive go/no-go decision-making criteria in early clinical development of agents to treat Alzheimer’s disease
Alette Wessels, PhD (1), Chris J. Edgar PhD (2), Gregory Light, PhD (3), Pradeep Nathan, PhD (4), Eric Siemers, MD (5), Paul Maruff, PhD (6), John Harrison, PhD (7)
(1) Eli Lilly and Company, Indianapolis, IN, USA, (2) Cogstate Ltd, London, UK, (3) Department of Psychiatry, University of California, San Diego, USA, (4) SoseiHeptares, Cambridge, UK; Department of Psychiatry, University of Cambridge UK; School of Psychological Sciences, Monash University, Australia, (5) Cogstate Ltd, New Haven, CT, USA, (6) Cogstate Ltd., Melbourne, Australia, (7) Metis Cognition Ltd, Kilmington Common, UK; Alzheimer Center AUmc, Amsterdam, The Netherlands; Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
Saturday, Dec 7th
8:00am – Late Breaking Oral Communication
LB22- Cut points for cognitive decline using MMSE define baseline and longitudinal differences in both clinical and pathological Alzheimer’s disease biomarkers
James Doecke (1), Marcela Cespedes (1), Cai Gillis (2), Nancy Maserejian (2), Pierrick Bourgeat (3), Chris Fowler (4), Victor Villemagne (5), Qiao-Xin Li (4), Steven Collins (4), Stephanie Rainey-Smith (6,7), Paul Maruff (4), Ralph Martins (6,8,9), David Ames (10), Colin Masters (4)
(1) Australian e-Health Research Centre, CSIRO, Australia, (2) Biogen, United States, (3) Australian e-Health Research Centre, CSIRO, Brisbane, QLD, Australia., Australia, (4) The Florey Institute, The University of Melbourne, Australia, (5) Austin Health, Department of Molecular Imaging and Therapy, Center for PET, Australia, (6) Sir James McCusker Alzheimer’s Disease Research Unit (Hollywood Private Hospital), Australia, (7) Centre of Excellence for Alzheimer’s disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Australia, (8) Department of Biomedical Sciences, Macquarie University, Australia, (9) School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia, (10) National Ageing Research Institute, Australia